Exploring the Continuous Glucose Monitoring in Pediatric Diabetes: Current Practices, Innovative Metrics, and Future Implications.

CGM children continuous glucose monitoring diabetes pediatrics time in range time in tight range type 1 diabetes type 2 diabetes

Journal

Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936

Informations de publication

Date de publication:
27 Jul 2024
Historique:
received: 24 06 2024
revised: 17 07 2024
accepted: 22 07 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Continuous glucose monitoring (CGM) systems, including real-time CGM and intermittently scanned CGM, have revolutionized diabetes management, particularly in children and adolescents with type 1 diabetes (T1D). These systems provide detailed insights into glucose variability and detect asymptomatic and nocturnal hypoglycemia, addressing limitations of traditional self-monitoring blood glucose methods. CGM devices measure interstitial glucose concentrations constantly, enabling proactive therapeutic decisions and optimization of glycemic control through stored data analysis. CGM metrics such as time in range, time below range, and coefficient of variation are crucial for managing T1D, with emerging metrics like time in tight range and glycemia risk index showing potential for enhanced glycemic assessment. Recent advancements suggest the utility of CGM systems in monitoring the early stages of T1D and individuals with obesity complicated by pre-diabetes, highlighting its therapeutic versatility. This review discusses the current CGM systems for T1D during the pediatric age, established and emerging metrics, and future applications, emphasizing the critical role of CGM devices in improving glycemic control and clinical outcomes in children and adolescents with diabetes.

Identifiants

pubmed: 39201842
pii: children11080907
doi: 10.3390/children11080907
pmc: PMC11352692
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Diabetes Care. 2019 Mar;42(3):400-405
pubmed: 30352896
J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236
pubmed: 35094087
Diabetes Technol Ther. 2024 Mar;26(3):203-210
pubmed: 38444315
Pediatr Diabetes. 2022 Nov;23(7):872-902
pubmed: 36161685
Pediatrics. 2023 Feb 1;151(2):
pubmed: 36622115
Diabetes Technol Ther. 2024 Mar;26(3):161-166
pubmed: 37902743
Diabetes Care. 2024 Jun 1;47(6):1084-1091
pubmed: 38626260
J Diabetes Sci Technol. 2024 Jul;18(4):771-778
pubmed: 38715286
Ital J Pediatr. 2023 Jun 8;49(1):69
pubmed: 37291604
Pediatr Diabetes. 2022 Dec;23(8):1270-1276
pubmed: 36537523
Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57
pubmed: 36493795
Diabetes Technol Ther. 2024 Mar;26(3):147-150
pubmed: 38156959
J Diabetes Sci Technol. 2024 Jul;18(4):787-794
pubmed: 38629861
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Diabetes Care. 2022 Feb 1;45(2):365-371
pubmed: 34880069
J Diabetes Sci Technol. 2024 Jul;18(4):835-846
pubmed: 38629784
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4356-4364
pubmed: 31127824
Diabetes Care. 2023 Oct 1;46(10):1770-1777
pubmed: 37478335
Horm Res Paediatr. 2021;94(9-10):369-373
pubmed: 34915493
Diabetes Care. 2023 Mar 1;46(3):526-534
pubmed: 36730530
J Diabetes Sci Technol. 2023 Sep;17(5):1326-1336
pubmed: 35470692
J Clin Endocrinol Metab. 2023 Dec 21;109(1):57-67
pubmed: 37572381
Diabetes Technol Ther. 2024 Mar;26(3):151-155
pubmed: 37870460
J Diabetes Sci Technol. 2024 Jul;18(4):779-786
pubmed: 38708581
Diabetes Care. 2021 May;44(5):1176-1184
pubmed: 33653821
Diabetes Care. 2024 May 1;47(5):782-784
pubmed: 38640413
Horm Res Paediatr. 2023 Dec 15;:
pubmed: 38104553
J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242
pubmed: 35348391
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetes Technol Ther. 2024 Mar;26(S1):S14-S31
pubmed: 38441451
Pediatr Diabetes. 2022 Dec;23(8):1390-1405
pubmed: 36537528
Diabetes Technol Ther. 2023 Jul;25(7):507-512
pubmed: 37155332
Diabetes Res Clin Pract. 2023 Apr;198:110618
pubmed: 36906234
Diabet Med. 2024 Aug;41(8):e15333
pubmed: 38671595
Pediatr Diabetes. 2019 May;20(3):339-344
pubmed: 30652407
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3337-3344
pubmed: 30844073

Auteurs

Agata Chobot (A)

Department of Pediatrics, Institute of Medical Sciences, University of Opole, 45-040 Opole, Poland.
Department of Pediatrics, University Clinical Hospital in Opole, 46-020 Opole, Poland.

Claudia Piona (C)

Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, 37126 Verona, Italy.

Bruno Bombaci (B)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98122 Messina, Italy.

Olga Kamińska-Jackowiak (O)

Department of Pediatrics, Institute of Medical Sciences, University of Opole, 45-040 Opole, Poland.
Department of Pediatrics, University Clinical Hospital in Opole, 46-020 Opole, Poland.

Valentina Mancioppi (V)

Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, 37126 Verona, Italy.

Stefano Passanisi (S)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98122 Messina, Italy.

Classifications MeSH